Domov › Melanóm › North Carolina

Klinické štúdie Melanóm v štáte North Carolina

31 štúdií pre Melanóm hľadá účastníkov v zariadeniach v štáte North Carolina.

Mestá v štáte North Carolina

Oficiálny text štúdie (anglicky)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Carolina Cancer Research Center, Wilson

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
a 6 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Lineberger Comprehensive Cancer Center, Chapel Hill

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07740941

DESTINY-PANTUMOUR04

Research Site, Durham
Research Site, Wilson

Prebieha náborObservačná štúdia

Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Messino Cancer Center, Asheville
Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte
a 3 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06246916

Pan-tumor MRD Study

Carolina Oncology Specialists, Charlotte
Southeastern Medical Oncology Center (SMOC), Goldsboro
Regional Medical Oncology Center, Wilson

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Duke Cancer Center Cary, Cary
Duke University Medical Center, Durham
Duke Cancer Center Raleigh, Raleigh

Prebieha náborFáza 3

Vek 75 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07068074

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Carolina Biooncology Institute, Huntersville

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT05267626

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0100, Durham

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Wake Forest University at Clemmons, Clemmons
Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
a 4 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

University of North Carolina, Chapel Hill

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07288112

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Duke Cancer Institute, Durham

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07070232

Project: Every Child for Younger Patients With Cancer

Mission Hospital, Asheville
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Carolinas Medical Center/Levine Cancer Institute, Charlotte
a 4 ďalších

Prebieha náborObservačná štúdia

Do veku 25 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT02402244

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Lineberger Comprehensive Cancer Center, Chapel Hill

Prebieha náborFáza 1

Vek 18 až 99 · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT03454035

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Huntersville

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT07749586

A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

Duke University Medical Center, Durham

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 7. 2026 · NCT05077137

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill

Prebieha náborFáza 1/2

Vek 18 až 70 · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Duke University Medical Center, Durham

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 6. 2026 · NCT03947385

IL-17 Blockade to Decrease irAEs (REPLAY)

Duke University Health System, Durham

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT07237594

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

University of North Carolina at Chapel Hill, Chapel Hill

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT06413680

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Duke University Medical Center, Durham

Prebieha náborFáza 2/3

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 4. 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Atrium Health Stanly/LCI-Albemarle, Albemarle
Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
a 21 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Carolina BioOncology Institute, Huntersville

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 1. 2026 · NCT07317505

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Duke University Medical Center - Duke Cancer Center, Durham

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 12. 2025 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chapel Hill
Massive Bio SYNERGY-AI site, Winston-Salem

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

Duke University Health System, Durham

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2025 · NCT05839912

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
East Carolina University, Greenville
a 1 ďalších

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 11. 2024 · NCT03860883

DermaSensor Postmarket Surveillance Study

West Clinical Research, Morehead City

Prebieha nábor

Vek 40 a viac · Všetky pohlavia · Aktualizované 31. 10. 2024 · NCT06666790

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.